Li Xiaoge, Wu Jin, Wu Yutong, Duan Zhaoning, Luo Ming, Li Ling, Li Sijing, Jia Ying
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Int J Womens Health. 2023 Jul 4;15:987-1002. doi: 10.2147/IJWH.S406596. eCollection 2023.
To explore the correlation of female vaginal microbiota and immune factors with cervical cancer.
The distribution pattern difference of vaginal microbiota of four groups of women (cervical cancer, HPV-positive CIN, HPV-positive non-CIN, and HPV-negative groups) were compared by microbial 16S rDNA sequencing. The protein chip was used to detect the composition and changes of the immune factors in the four groups.
Alpha diversity analysis demonstrated that the diversity of the vaginal microbiota was increased as the disease develops. Among those bacteria abundant in the vaginal microbiota, , and dominate at the genus level of vaginal flora. Compared with the HPV-negative group, the differentially dominant bacteria, such as and , are enriched in the cervical cancer group. Likewise, , and are more in the HPV-positive CIN group, while and in the HPV-positive non-CIN group, respectively. In contrast, and are dominant in the HPV-negative group (LDA>4log10). The concentration of inflammatory immune factors IP-10 and VEGF-A were increased in the cervical cancer group ( < 0.05), compared with other groups.
The occurrence of cervical cancer is related to an increase of vaginal microbiota diversity and up-regulation of inflammatory immune factor proteins. The abundance of was decreased while the one of and were increased in the cervical cancer group, compared with other three groups. Moreover, the IP-10 and VEGF-A were also increased in the cervical cancer group. Thus, evaluation of changes in the vaginal microbiota and these two immune factor levels might be a potential non-invasive and simple method to predict cervical cancer. Furthermore, it is significant to adjust and restore the balance of vaginal microbiota and maintain normal immune function in preventing and treating cervical cancer.
探讨女性阴道微生物群和免疫因子与宫颈癌的相关性。
采用微生物16S rDNA测序比较四组女性(宫颈癌组、HPV阳性CIN组、HPV阳性非CIN组和HPV阴性组)阴道微生物群的分布模式差异。用蛋白质芯片检测四组免疫因子的组成及变化。
α多样性分析表明,阴道微生物群的多样性随疾病发展而增加。在阴道微生物群中丰富的细菌中,在阴道菌群属水平上以 、 和 为主。与HPV阴性组相比,宫颈癌组中差异优势菌如 和 富集。同样,HPV阳性CIN组中 、 和 更多,而HPV阳性非CIN组中分别为 和 。相比之下, 和 在HPV阴性组中占主导(LDA>4log10)。与其他组相比,宫颈癌组中炎性免疫因子IP-10和VEGF-A的浓度升高( < 0.05)。
宫颈癌的发生与阴道微生物群多样性增加和炎性免疫因子蛋白上调有关。与其他三组相比,宫颈癌组中 的丰度降低,而 和 的丰度增加。此外,宫颈癌组中IP-10和VEGF-A也升高。因此,评估阴道微生物群和这两种免疫因子水平的变化可能是一种潜在的非侵入性简单方法来预测宫颈癌。此外,调节和恢复阴道微生物群平衡并维持正常免疫功能在预防和治疗宫颈癌方面具有重要意义。